Calculated based on number of publications stored in Pure and citations from Scopus
1991 …2024

Research activity per year

Network

Hagop M. Kantarjian

  • University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • MDACC
  • Department of Biostatistics
  • University of Dundee
  • Medical Breast Service
  • University of Texas at Austin
  • Merck
  • Department of Bioimmunotherapy
  • Novartis Pharmaceuticals
  • Rambam Health Care Campus Israel
  • Leukemia
  • Division of Stem Cell Transplantation and Cellular Therapy
  • Fudan University
  • Children's Memorial Hospital
  • Johnson & Johnson
  • Singapore General Hospital
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Daiichi Pharmaceutical Corporation
  • St. Vincent's Hospital Melbourne
  • National Institutes of Health
  • Investigational Drug Branch
  • Icahn School of Medicine at Mount Sinai
  • Department of Lymphoma and Myeloma
  • Department of Leukemia
  • Novartis
  • Department of Leukemia
  • The University of Texas M. D. Anderson Cancer Center
  • University of Texas Health Science Center at Houston
  • Texas State University
  • Departments of Leukemia

External person

Susan O'brien

  • MDACC
  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of California at Irvine
  • University of Dundee
  • Merck
  • Department of Bioimmunotherapy
  • Novartis Pharmaceuticals
  • Goethe University Frankfurt
  • Leukemia
  • University of Texas at Austin
  • Children's Memorial Hospital
  • Singapore General Hospital
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • MD Anderson Cancer Center
  • Novartis
  • The University of Texas M. D. Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Farhad Ravandi

  • University of Texas MD Anderson Cancer Center
  • MDACC
  • Department of Leukemia
  • University of Dundee
  • Department of Bioimmunotherapy
  • University of Texas at Austin
  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Illinois at Chicago
  • Department of Leukemia
  • Department of Leukemia
  • The University of Texas M. D. Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Guillermo Garcia-Manero

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • MDACC
  • University of Dundee
  • Novartis Pharmaceuticals
  • Johnson & Johnson
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Daiichi Pharmaceutical Corporation
  • National Institutes of Health
  • Investigational Drug Branch
  • Novartis
  • The University of Texas M. D. Anderson Cancer Center
  • University of Texas Health Science Center at Houston
  • Department of Leukemia
  • University of Michigan, Ann Arbor

External person

Elias Jabbour

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas at Austin
  • Division of Stem Cell Transplantation and Cellular Therapy
  • Fudan University
  • University of California at Irvine
  • University of Texas Health Science Center at Houston
  • Department of Leukemia

External person

Gautam Borthakur

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston
  • Division of Stem Cell Transplantation and Cellular Therapy

External person

Francis J. Giles

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at San Antonio
  • Department of Infectious Diseases
  • Department of Leukemia
  • Trinity College Dublin
  • Merck
  • Department of Bioimmunotherapy
  • Novartis Pharmaceuticals
  • University of Texas at San Antonio
  • Goethe University Frankfurt
  • Leukemia
  • University of Galway
  • University of Texas Health Science Center
  • GlaxcoSmithKline
  • Children's Memorial Hospital
  • Northwestern Medicine Developmental Therapeutics Institute
  • Johnson & Johnson
  • Singapore General Hospital
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Daiichi Pharmaceutical Corporation
  • Department of Leukemia
  • National Institutes of Health
  • Investigational Drug Branch
  • HRB Clinical Research Facility
  • Novartis
  • University of Texas Health Science Center at Houston

External person

S. Pierce

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • MDACC
  • Leukemia
  • Children's Memorial Hospital
  • University of Texas at Austin
  • University of Washington
  • Singapore General Hospital
  • St. Vincent's Hospital Melbourne
  • University of Texas Health Science Center at Houston

External person

Srdan Verstovsek

  • University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • St. Vincent's Hospital Melbourne
  • University of Texas Health Science Center at Houston
  • Department of Leukemia

External person

Stefan Faderl

  • Rutgers - The State University of New Jersey, Newark
  • University of Medicine and Dentistry of New Jersey
  • MDACC
  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Bioimmunotherapy
  • University of Dundee
  • Merck
  • Novartis Pharmaceuticals
  • University of Texas at Austin
  • Johnson & Johnson
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Daiichi Pharmaceutical Corporation
  • John Theurer Cancer Center
  • Jazz Pharmaceuticals
  • Novartis
  • The University of Texas M. D. Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Tapan Kadia

  • MDACC
  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston
  • Department of Leukemia

External person

D. Thomas

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Novartis Pharmaceuticals
  • University of Texas at Austin
  • Johnson & Johnson
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Daiichi Pharmaceutical Corporation
  • St. Vincent's Hospital Melbourne
  • Department of Leukemia
  • Department of Bioimmunotherapy
  • Novartis
  • University of Texas Health Science Center at Houston

External person

Marina Konopleva

  • University of Texas MD Anderson Cancer Center
  • Division of Stem Cell Transplantation and Cellular Therapy
  • Department of Leukemia
  • Sect. of Molec. Hematology/Therapy
  • Department of Leukemia
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Naval Daver

  • MDACC
  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Leukemia
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Z. Estrov

  • University of Texas MD Anderson Cancer Center
  • Department of Bioimmunotherapy
  • Department of Leukemia
  • University of Texas Health Science Center at Houston
  • Department of Leukemia

External person

Alfonso Quintás-Cardama

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Novartis
  • University of Texas Health Science Center at Houston

External person

Moshe Talpaz

  • Comprehensive Cancer Center
  • University of Michigan, Ann Arbor
  • University of Texas MD Anderson Cancer Center
  • Life Sciences Institute, Division of Hematology-Oncology, University of Michigan
  • Department of Internal Medicine
  • Department of Bioimmunotherapy
  • Merck
  • Novartis Pharmaceuticals
  • Department of Leukemia
  • Life Sciences Institute
  • MD Anderson Cancer Center
  • Department of Experimental Therapeutics
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Michigan Medical Center
  • Novartis
  • Department of Internal Medicine
  • Comprehensive Cancer Center
  • University of Texas Health Science Center at Houston

External person

William Wierda

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Naveen Pemmaraju

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston
  • Department of Leukemia

External person

Michael J. Keating

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Children's Memorial Hospital
  • University of Texas at Austin
  • Singapore General Hospital
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • St. Vincent's Hospital Melbourne
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Michael Andreeff

  • University of Texas MD Anderson Cancer Center
  • Division of Stem Cell Transplantation and Cellular Therapy
  • Department of Leukemia
  • Leukemia
  • Sect. of Molec. Hematology/Therapy
  • Children's Memorial Hospital
  • Singapore General Hospital
  • University of Texas Health Science Center at Houston
  • Texas State University

External person

Elihu E. Estey

  • University of Washington
  • Department of Medicine
  • University of Texas MD Anderson Cancer Center
  • Department of Infectious Diseases
  • Department of Leukemia
  • Leukemia
  • Fred Hutchinson Cancer Research Center
  • Clinical Research Division
  • GlaxcoSmithKline
  • University of Texas at Austin
  • Department of Medicine
  • Johnson & Johnson
  • Singapore General Hospital
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • National Institutes of Health
  • Investigational Drug Branch
  • University of Texas Health Science Center at Houston

External person

C. Dinardo

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Alessandra Ferrajoli

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Mary Beth Rios

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Novartis Pharmaceuticals
  • Novartis
  • University of Texas Health Science Center at Houston

External person

Carlos E. Bueso-Ramos

  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • The University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology and Molecular Diagnostics
  • Department of Leukemia
  • University of Texas at Austin
  • Department of Pathology
  • University of Texas Health Science Center at Houston
  • Department of Leukemia

External person

Keyur P. Patel

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Department of Hematopathology and Molecular Diagnostics
  • Department of Hematopathology
  • Department of Leukemia
  • University of Texas MD Anderson Cancer Center, Department of Pathology, Unit 085
  • University of Texas Health Science Center at Houston

External person

Andreas Hochhaus

  • Friedrich Schiller University Jena
  • Heidelberg University 
  • Univeristate Heidelberg
  • Universitätsklinikum Jena
  • Universitaetsklinikum Jena
  • Universitätstsklinikum Jena
  • Universitä Tsklinikum Jena

External person

Charles Koller

  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • Department of Leukemia
  • University of Texas at Austin
  • Children's Memorial Hospital
  • Singapore General Hospital
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Maher Albitar

  • University of Texas MD Anderson Cancer Center
  • M.D. Anderson Cancer Center
  • Division of Laboratory Medicine
  • Quest Diagnostics Incorporated
  • Department of Leukemia
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Department of Pathology
  • Departments of Oncology/Hematopathology and Research and Development
  • Quest Diagnostics
  • Department of Biostatistics
  • Johnson & Johnson
  • Laboratory Medicine
  • Novartis Pharmaceuticals
  • NeoGenomics Laboratories
  • Novartis
  • University of Texas Health Science Center at Houston

External person

Jianqin Shan

  • University of Texas MD Anderson Cancer Center
  • Merck
  • Department of Bioimmunotherapy
  • Department of Leukemia
  • Novartis Pharmaceuticals
  • Novartis
  • University of Texas Health Science Center at Houston

External person

Nitin Jain

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston
  • Department of Leukemia

External person

Steven M. Kornblau

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Division of Stem Cell Transplantation and Cellular Therapy
  • Dan L. Duncan Cancer Center
  • Baylor College of Medicine
  • Singapore General Hospital
  • University of Texas at Austin
  • National Institutes of Health
  • Investigational Drug Branch
  • University of Texas Health Science Center at Houston
  • Texas State University

External person

Koji Sasaki

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Tokyo Medical and Dental University
  • University of Texas Health Science Center at Houston

External person

Miloslav Beran

  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • Department of Leukemia
  • University of Texas at Austin
  • Children's Memorial Hospital
  • Singapore General Hospital
  • University of Texas Health Science Center at Houston

External person

Nicholas J. Short

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Raja Luthra

  • University of Texas MD Anderson Cancer Center
  • Department of Pathology
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Kyoto University
  • University of Texas Health Science Center at Houston

External person

Dong Wook Kim

  • The Catholic University of Korea
  • Department of Internal Medicine
  • Catholic Hematopoietic Stem Cell Bank
  • Seoul St. Mary's Hospital
  • Seoul St. Mary's Hospital
  • St. Mary's Hospital
  • Uijeongbu Eulji Medical Center
  • St. Mary's Hospital
  • Eulji University

External person

Koichi Takahashi

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Kyoto University
  • Institute ForAppliedCancer Science, Department of Genomic Medicine, University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Xuelin Huang

  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • Department of Leukemia
  • Department of Biostatistics
  • University of Texas Health Science Center at Houston

External person

Michael J. Mauro

  • Medical College of Wisconsin
  • Oregon Health and Science University
  • Memorial Sloan-Kettering Cancer Center
  • Knight Cancer Institute

External person

Richard E. Champlin

  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Case Western Reserve University
  • University of Texas Health Science Center at Houston

External person

Timothy Hughes

  • South Australian Health And Medical Research Institute
  • Institute of Medical and Veterinary Science Australia
  • University of Adelaide
  • Centre for Cancer Biology
  • Royal Adelaide Hospital
  • School of Medicine
  • SA Pathology
  • Division of Hematology

External person

Michael W. Deininger

  • University of Utah
  • Huntsman Cancer Institute
  • Division of Hematology and Hematologic Malignancies
  • Department of Internal Medicine
  • Oregon Health and Science University
  • Department of Oncological Sciences
  • Division of Hematology and Medical Oncology
  • Knight Cancer Institute
  • Versiti Blood Research Institute
  • Versiti
  • Medical College of Wisconsin

External person

Dan Jones

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Department of Hematopathology
  • Quest Diagnostics Incorporated
  • University of Texas Health Science Center at Houston
  • Box 72
  • Ohio State University

External person

J. A. Burger

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Leukemia
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

T. Manshouri

  • M.D. Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Division of Laboratory Medicine
  • Department of Leukemia
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Michele Baccarani

  • University of Bologna
  • S. Orsola-Malpighi Polyclinic
  • Azienda Ospedaliero-Universitaria di Bologna Policlinico S. Orsola – Malpighi

External person

Jeffrey L. Jorgensen

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Department of Hematopathology and Molecular Diagnostics
  • Department of Leukemia
  • Department of Biostatistics
  • University of Texas MD Anderson Cancer Center, Department of Pathology, Unit 085
  • University of Texas Health Science Center at Houston

External person

Preetesh Jain

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Division of Cancer Medicine
  • Division of Clinical and Translational Sciences
  • University of Texas Health Science Center at Houston

External person

Yesid Alvarado

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

E. J. Freireich

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Children's Memorial Hospital
  • University of Texas at Austin
  • University of Texas Health Science Center at Houston

External person

Jerald P. Radich

  • Fred Hutchinson Cancer Research Center
  • Clinical Research Division
  • University of Washington
  • Newcastle University
  • Frederick Hutchinson Cancer Research Center

External person

Mark Brandt

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Ghayas C. Issa

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Biostatistics
  • University of Texas Health Science Center at Houston

External person

L. Jeffrey Medeiros

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Department of Pathology
  • University of Texas Health Science Center at Houston

External person

Jane F. Apperley

  • Imperial College London
  • Imperial College Healthcare NHS Trust
  • Department of Haematology
  • European Group for Blood and Marrow Transplantation
  • Hammersmith Hospital
  • European Group for Blood and Marrow Transplantation

External person

Hanna Jean Khoury

  • Emory University
  • Clark Atlanta University
  • Department of Hematology and Medical Oncology Winship
  • Department of Hematology and Medical Oncology, Emory University School of Medicine
  • Department of Hematology and Medical Oncology
  • School of Medicine
  • Department of Hematology and Oncology

External person

Carlo Gambacorti-Passerini

  • University of Milan - Bicocca
  • Azienda Ospedaliera San Gerardo Monza
  • McGill University

External person

J. Lipton

  • Canterbury District Health Board
  • University of Toronto
  • Medical College of Wisconsin
  • University Health Network
  • Department of Medical Oncology and Hematology
  • Princess Margaret Hospital

External person

Maro Ohanian

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston
  • Department of Leukemia

External person

Marcos de Lima

  • Case Western Reserve University
  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston
  • Seidman Cancer Center

External person

Graciela M. Nogueras-González

  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • Department of Leukemia
  • University of Texas Health Science Center at Houston
  • Departments of Biostatistics

External person

Sa A. Wang

  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • The University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Harbin Medical University
  • University of Texas Health Science Center at Houston

External person

Xuemei Wang

  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • Biostatistics Department and
  • University of Texas Health Science Center at Houston
  • Augusta University

External person

Rebecca Garris

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Giuseppe Saglio

  • University of Turin
  • Azienda Ospedaliera S. Luigi Gonzaga
  • European Group for Blood and Marrow Transplantation
  • Orbassano University Hospital
  • Department of Clinical and Biological Sciences
  • European Group for Blood and Marrow Transplantation

External person

Kiran Naqvi

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston
  • Genentech Incorporated

External person

Partow Kebriaei

  • University of Texas M.D. Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas Health Science Center at Houston

External person

Tim H. Brümmendorf

  • RWTH Aachen University
  • University Medical Center Hamburg-Eppendorf
  • Aachen-Bonn-Cologne-Duesseldorf

External person

Prithviraj Bose

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston
  • Department of Leukemia

External person

Richard A. Larson

  • The University of Chicago

External person

Giovanni Martinelli

  • University of Bologna
  • IRCCS Istituto scientifico romagnolo per lo studio e la cura dei tumori - Meldola (FC)
  • L. e A. Seragnoli Institute of Hematology
  • S. Orsola-Malpighi Polyclinic
  • Azienda Ospedaliero-Universitaria di Bologna Policlinico S. Orsola – Malpighi

External person

Musa Yilmaz

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Hematology and Oncology
  • Baylor College of Medicine
  • University of Texas Health Science Center at Houston

External person

Rashmi Kanagal-Shamanna

  • Department of Hematopathology and Molecular Diagnostics
  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Hematopathology
  • University of Texas Health Science Center at Houston

External person

François Guilhot

  • CHU de Poitiers
  • Université de Poitiers
  • University Miletrie Hospital
  • Institut national de la santé et de la recherche médicale

External person

Joseph D. Khoury

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston
  • Department of Leukemia
  • University of Nebraska Medical Center

External person

Philipp le Coutre

  • Charité – Universitätsmedizin Berlin
  • Humboldt University of Berlin

External person

J. Pinilla-Ibarz

  • H. Lee Moffitt Cancer Center
  • University of South Florida
  • Immunology Program

External person

Franck E. Nicolini

  • Hospices civils de Lyon
  • Hôpital Édouard Herriot
  • Hematology Department 1G
  • SociétéFrançaise de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
  • European Group for Blood and Marrow Transplantation
  • French Group of CML (Fi-LMC Group)
  • Universite Claude Bernard Lyon 1
  • Institut national de la santé et de la recherche médicale
  • National Institutes of Health, Bethesda
  • National Institutes of Health
  • Centre Léon Bérard
  • Hospices Civils de Lyon
  • European Group for Blood and Marrow Transplantation
  • Centre de Recherche en Cancérologie de Lyon

External person

Brian J. Druker

  • Oregon Health and Science University
  • Division of Hematology and Medical Oncology
  • Howard Hughes Medical Institute
  • Knight Cancer Institute
  • Newcastle University

External person

Charles Chuah

  • Singapore General Hospital
  • Graduate Medical School
  • National University of Singapore
  • Cancer and Stem Cell Biology Program
  • Duke
  • Duke-National University of Singapore Graduate Medical School

External person

Jean Pierre Issa

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Temple University
  • Johns Hopkins University
  • University of Texas Health Science Center at Houston

External person

Cameron C. Yin

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Lynne Abruzzo

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • College of Medicine
  • Ohio State University
  • University of Texas Health Science Center at Houston
  • University of Ferrara

External person

Lucia Masarova

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston
  • Department of Leukemia

External person

Prajwal Boddu

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Varsha Gandhi

  • University of Texas MD Anderson Cancer Center
  • Department of Experimental Therapeutics
  • MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Mark Levis

  • Johns Hopkins University
  • Department of Oncology
  • Oncology Department
  • Sidney Kimmel Comprehensive Cancer Center, Department of Oncology, Johns Hopkins University

External person

Aziz Nazha

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Cleveland Clinic Foundation
  • Department of Hematologic Oncology and Blood Disorders
  • University of Texas at Austin
  • University of Texas Health Science Center at Houston

External person

Neil P. Shah

  • University of California at San Francisco
  • Department of Medicine
  • Department of Medicine, University of California-San Francisco

External person

Daniel J. DeAngelo

  • Harvard University
  • Department of Medical Oncology
  • Dana-Farber Cancer Institute
  • Department of Medicine
  • Department of Medical Oncology, Dana-Farber Cancer Institute
  • Dana

External person

Sergio Giralt

  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas MD Anderson Cancer Center
  • Memorial Sloan-Kettering Cancer Center
  • Department of Medicine, Memorial Sloan Kettering Cancer Center
  • Hematology Service
  • University of Texas Health Science Center at Houston

External person

Kapil N. Bhalla

  • Augusta University
  • University of Texas MD Anderson Cancer Center
  • University of South Florida
  • Georgia Prevention Center
  • University of Texas Health Science Center at Houston
  • University of Kansas
  • The University of Kansas
  • Houston Methodist
  • Medical College of Georgia

External person

Guillermo Montalban-Bravo

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

William Plunkett

  • University of Texas MD Anderson Cancer Center
  • Department of Experimental Therapeutics
  • University of Dundee
  • Department of Leukemia
  • MD Anderson Cancer Center
  • The University of Texas M. D. Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Ayalew Tefferi

  • Mayo Clinic College of Medicine and Science
  • Mayo Clinic Rochester, MN
  • Department of Internal Medicine
  • Division of Hematology
  • Divisions of Cardiovascular Diseases and Pediatric Cardiology, Departments of Medicine, Pediatrics, and Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic
  • Department of Hematology
  • Division of Gastroenterology and Hepatology
  • Mayo Clinic College of Medicine and Science

External person

O. G. Ottmann

  • Cardiff University
  • Department of Haematology
  • Goethe University Frankfurt
  • Novartis Pharmaceuticals
  • Goethe Universität Frankfurt Am Main

External person

Sergej Konoplev

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Sanam Loghavi

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center, Department of Pathology, Unit 085
  • University of Texas Health Science Center at Houston

External person

Apostolia Tsimberidou

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Fabio P.S. Santos

  • University of Texas MD Anderson Cancer Center
  • Hospital Israelita Albert Einstein
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Razelle Kurzrock

  • University of Texas MD Anderson Cancer Center
  • Medical Breast Service
  • Department of Bioimmunotherapy
  • Rambam Health Care Campus Israel
  • Department of Leukemia
  • Unit 422
  • University of California at San Diego
  • Johnson & Johnson
  • University of Texas Health Science Center at Houston

External person

Michael Rytting

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Pediatrics
  • University of Texas Health Science Center at Houston

External person

Sima Jeha

  • University of Texas MD Anderson Cancer Center
  • Novartis Pharmaceuticals
  • Daiichi Pharmaceutical Corporation
  • Department of Pediatrics
  • St. Jude Children Research Hospital
  • Department of Bioimmunotherapy
  • Novartis
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Kate J. Newberry

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Uday Popat

  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston
  • Department of Leukemia

External person

B. Nebiyou Bekele

  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • University of Texas Health Science Center at Houston

External person

Gianantonio Rosti

  • University of Bologna
  • Institute of Hematology and Medical Oncology Seràgnoli
  • S. Orsola-Malpighi Polyclinic
  • Institute of Hematology and Medical Oncology Seràgnoli
  • Azienda Ospedaliero-Universitaria di Bologna Policlinico S. Orsola – Malpighi
  • IRCCS Istituto scientifico romagnolo per lo studio e la cura dei tumori - Meldola (FC)

External person

Wei Qiao

  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

François Xavier Mahon

  • CHU de Bordeaux
  • Centre Georges-François Leclerc
  • Institut national de la santé et de la recherche médicale
  • Groupe hospitalier Pellegrin
  • Hôpital Cardiologique du Haut-Lévêque
  • French Group of CML (Fi-LMC Group)
  • Université de Bordeaux
  • CNRS
  • Université de Bordeaux
  • Université Victor Segelen

External person

Pau Montesinos

  • Hospital Universitario La Fe
  • Instituto de Salud Carlos III
  • Centro de Investigación Biomédica en Red
  • Centro de Investigación Biomédica en Red

External person

Philippe Rousselot

  • Université Paris-Saclay
  • ComUE Paris-Saclay
  • Université Paris 7
  • Université Versailles Saint-Quentin-en-Yvelines Paris-Saclay U1173
  • Université Paris Cité
  • Centre Hospitalier de Versailles

External person

Richard M. Stone

  • Dana-Farber Cancer Institute
  • Department of Medical Oncology, Dana-Farber Cancer Institute
  • Harvard University
  • Department of Medical Oncology
  • Dana-Farber/Harvard Cancer Center

External person

Christopher B. Benton

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

John Goldman

  • Hammersmith Hospital
  • Imperial College London
  • National Institutes of Health

External person

Shimin Hu

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Delphine Rea

  • Université Paris 7
  • Université Paris Cité

External person

S. Lerner

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Elisabetta Abruzzese

  • University of Rome Tor Vergata
  • ASL Roma 2

External person

Jeffrey E. Lancet

  • University of South Florida
  • Immunology Program

External person

Martin S. Tallman

  • Memorial Sloan-Kettering Cancer Center
  • Department of Medicine, Memorial Sloan Kettering Cancer Center
  • Robert H. Lurie Compreh. Cancer Ctr.
  • Northwestern University
  • Cornell University
  • Children's Memorial Hospital

External person

Meir Wetzler

  • Leukemia Section
  • Roswell Park Cancer Institute
  • Novartis Pharmaceuticals Corporation
  • Novartis

External person

Wei Wang

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Hervé Dombret

  • Université Paris 7
  • Université Paris Cité

External person

Sara Dellasala

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Ehab Atallah

  • Division of Hematology and Oncology
  • Medical College of Wisconsin
  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Jenny Shan

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Marylou Cardenas-Turanzas

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Jing Ning

  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • University of Texas Health Science Center at Houston

External person

Abhishek Maiti

  • Department of Internal Medicine
  • University of Texas Health Science Center at Houston
  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia

External person

Gloria N. Mattiuzzi

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Susan Branford

  • Institute of Medical and Veterinary Science Australia
  • University of South Australia
  • Centre for Cancer Biology
  • University of Adelaide
  • School of Medicine
  • Genetics and Molecular Pathology

External person

S. Goldberg

  • John Theurer Cancer Center, Hackensack University Medical Center
  • Rutgers - The State University of New Jersey, Newark
  • University of Medicine and Dentistry of New Jersey

External person

Philip Thompson

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Richard T. Maziarz

  • Oregon Health Sciences University
  • Oregon Health and Science University

External person

Neil P. Shah

  • University of California at San Francisco
  • University College of Los Angeles
  • University of California at Los Angeles
  • UCLA School of Medicine
  • University College of Los Angeles

External person

Lianchun Xiao

  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • Department of Biostatistics
  • University of Texas Health Science Center at Houston
  • Biostatistics

External person

Richard Silver

  • Cornell University
  • New York Presbyterian Hospital
  • Scripps Clinic

External person

Mary M. Horowitz

  • Medical College of Wisconsin
  • Center for International Blood and Marrow Transplant Research
  • Center for International Blood and Marrow Transplant Research
  • TOPS Obesity and Metabolic Research Center
  • Center for International Blood and Marrow Transplant Research

External person

Paolo Strati

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Rita Assi

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Lebanese American University

External person

Patricia Ault

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Guilin Tang

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Constantine S. Tam

  • University of Texas MD Anderson Cancer Center
  • University of Melbourne
  • Peter Maccallum Cancer Centre
  • St. Vincent's Hospital Melbourne
  • University of Texas Health Science Center at Houston

External person

Vivian Oehler

  • Fred Hutchinson Cancer Research Center
  • Clinical Research Division
  • Seattle Cancer Care Alliance

External person

Matt Kalaycio

  • Cleveland Clinic Foundation
  • Dept. of Hematol. and Med. Oncology
  • Department of Hematology/Medical Oncology
  • Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic
  • Department of Hematology and Oncology

External person

Gary J. Schiller

  • University of California at Los Angeles

External person

Alexander E. Perl

  • University of Pennsylvania

External person

H. Yang

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Terry L. Smith

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Children's Memorial Hospital
  • University of Texas Health Science Center at Houston

External person

Ralph Arlinghaus

  • University of Texas MD Anderson Cancer Center
  • Novartis Pharmaceuticals
  • Novartis
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Koji Sasaki

  • Tokyo Medical and Dental University
  • University of Texas MD Anderson Cancer Center

External person

Martin C. Müller

  • Heidelberg University 
  • Institute for Hematology and Oncology

External person

Mark Litzow

  • Department of Internal Medicine
  • Mayo Clinic Rochester, MN
  • Mayo Clinic College of Medicine and Science
  • Department of Internal Medicine
  • Department of Hematology
  • Yale University
  • Mayo Clinic College of Medicine and Science

External person

Lingsha Zhou

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • St. Vincent's Hospital Melbourne
  • University of Texas Health Science Center at Houston
  • Department of Leukemia

External person

Ricardo Pasquini

  • Universidade Federal do Paraná
  • Hospital de Clínicas de Curitiba

External person

Gail J. Roboz

  • Cornell University
  • Division of Hematology and Oncology
  • Department of Medicine, Weill Cornell Medical College, New York Presbyterian Hospital
  • New York Presbyterian Hospital
  • Burke Cornell Medical Center

External person

E. Ritchie

  • Cornell University
  • Weill Cornell Medical College of Cornell University
  • Burke Cornell Medical Center

External person

Wael Saber

  • Medical College of Wisconsin
  • TOPS Obesity and Metabolic Research Center
  • Center for International Blood and Marrow Transplant Research
  • Center for International Blood and Marrow Transplant Research

External person

Robert Peter Gale

  • IAVI Human Immunology Laboratory
  • Imperial College London
  • Center for Advanced Studies in Leukemia
  • Celgene Corporation

External person

Issa Khouri

  • University of Texas MD Anderson Cancer Center
  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas Health Science Center at Houston

External person

Rüdiger Hehlmann

  • Heidelberg University 
  • ELN Foundation

External person

M. A. Sekeres

  • Cleveland Clinic Foundation
  • University of Miami

External person

Valentin Garcia-Gutierrez

  • Hospital Ramon y Cajal
  • Ramón y Cajal Health Research Institute

External person

Dushyant Verma

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Teresa McQueen

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas Health Science Center at Houston

External person

Francisco Cervantes

  • University of Barcelona
  • August Pi i Sunyer Biomedical Research Institute

External person

Simona Soverini

  • University of Bologna
  • S. Orsola-Malpighi Polyclinic
  • Azienda Ospedaliero-Universitaria di Bologna Policlinico S. Orsola – Malpighi

External person

Yang Huh

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Children's Memorial Hospital
  • University of Texas Health Science Center at Houston

External person

Hong Mu

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Donna Hogge

  • Leukemia/Bone Marrow Transplant Program of British Columbia
  • University of British Columbia
  • British Columbia Cancer Agency

External person

Betul Oran

  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Ruben A. Mesa

  • Mayo Clinic Scottsdale, AZ
  • Division of Hematology and Medical Oncology
  • University of Texas Health Science Center

External person

Anna Turkina

  • Russian Academy of Medical Sciences

External person

Geoffrey Chan

  • Pfizer Oncology
  • Pfizer

External person

Adam Craig

  • A Wholly Owned Subsidiary of Teva Branded Pharmaceutical Products RandD, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Cephalon, Inc.
  • Sunesis Pharmaceuticals

External person

John F. DiPersio

  • Washington University St. Louis
  • Division of Medical Oncology
  • Department of Medicine
  • University of Toronto
  • Ontario Institute for Cancer Research

External person

Mary Ann Richie

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Charles Schiffer

  • Wayne State University

External person

Ronald Paquette

  • UCLA Division of Hematology/Oncology
  • University of California at Los Angeles
  • UCLA School of Medicine
  • Department of Medicine
  • Cedars-Sinai Medical Center

External person

Kim Anh Do

  • University of Texas MD Anderson Cancer Center
  • Biostatistics Department and
  • Department of Biostatistics
  • University of Texas Health Science Center at Houston

External person

Luke Akard

  • Indiana Blood and Marrow Transplantation
  • St. Francis Hospital and Health Centers
  • Indiana Blood and Marrow Transplantation
  • Indiana Blood and Marrow Transplantation St. Francis Franciscan Alliance

External person

Kimberly Hayes

  • University of Texas MD Anderson Cancer Center
  • University of Texas at Austin
  • Singapore General Hospital
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Charles A. Schiffer

  • Wayne State University

External person

Duncan H. Mak

  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Bing Z. Carter

  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Baldeep Wirk

  • Stony Brook University
  • Seattle Cancer Care Alliance
  • University of Florida
  • Department of Internal Medicine
  • Seattle Cancer Care Alliance

External person

Elizabeth J. Shpall

  • University of Texas M.D. Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Division of Stem Cell Transplantation and Cellular Therapy
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Susanne Saussele

  • Heidelberg University 

External person

Xian Zhou

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Andrew Wei

  • Monash University
  • Alfred Health
  • Peter Maccallum Cancer Centre
  • Walter and Eliza Hall Institute of Medical Research

External person

B. Douglas Smith

  • Sidney Kimmel Cancer Center at Johns Hopkins
  • Johns Hopkins University
  • Department of Oncology
  • Sidney Kimmel Comprehensive Cancer Center, Department of Oncology, Johns Hopkins University

External person

M. H. Qazilbash

  • University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Division of Stem Cell Transplantation and Cellular Therapy
  • Case Western Reserve University
  • University of Texas Health Science Center at Houston

External person

Elza Lomaia

  • Russian Ministry of Health
  • Blood and Endocrinology Centre

External person

Robert K. Stuart

  • Division of Hematology/Oncology, Department of Medicine, Medical University of South Carolina
  • Medical University of South Carolina
  • Hollings Cancer Center

External person

Carmen Fava

  • University of Texas MD Anderson Cancer Center
  • University of Turin
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Talha Badar

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Mayo Clinic Jacksonville, FL

External person

Zhihong Zeng

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Sherry Pierce

  • University of Texas Health Science Center at Houston
  • University of Texas MD Anderson Cancer Center

External person

Gabriela Rondon

  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Carolina Pavlovsky

  • Angelica Ocampo Hospitalization and Clinical Research Center

External person

Kiyomi Morita

  • The University of Tokyo
  • University of Texas MD Anderson Cancer Center

External person

David Marks

  • National Health Service
  • University Hospitals Bristol and Weston NHS Foundation Trust
  • University of Bristol
  • Bristol Adult BMT Unit
  • Bristol Royal Hospital for Children

External person

Carol Bivins

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

John Wright

  • National Institutes of Health
  • Cancer Therapy Evaluation Program
  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Mahran Shoukier

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Augusta University
  • Georgia Regents University Cancer Center
  • Medical College of Georgia

External person

Stefan E. Ciurea

  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Mahmoud D. Aljurf

  • King Faisal Specialist Hospital and Research Centre
  • Alfaisal University

External person

Monica Kwari

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • National Institutes of Health
  • Investigational Drug Branch
  • University of Texas Health Science Center at Houston

External person

Frank G. Haluska

  • ARIAD Pharmaceuticals, Inc.
  • Takeda Pharmaceutical Company Limited

External person

Geoffrey L. Uy

  • Washington University St. Louis
  • Department of Medicine

External person

Celalettin Ustun

  • University of Minnesota Twin Cities
  • Augusta University
  • Division of Hematology
  • Department of Medicine
  • Department of Medicine
  • Department of Internal Medicine
  • East Carolina University
  • Division of Hematology Oncology and Transplantation
  • Section of Hematology/Oncology
  • Department of Medicine
  • Division of Hematology-Oncology and Transplantation
  • Rush University
  • University of Minnesota System
  • Fairview Health Service
  • Medical College of Georgia

External person

Stephen A. Strickland

  • Vanderbilt University
  • Department of Medicine

External person

Jiří Mayer

  • Masaryk University

External person

M. Breccia

  • University of Rome La Sapienza

External person

Jonathan E. Kolitz

  • Institute
  • Northwell Health System
  • Hofstra University
  • Northwell Health System
  • Hofstra North Shore-LIJ School of Medicine

External person

Borje S. Andersson

  • University of Texas MD Anderson Cancer Center
  • Division of Stem Cell Transplantation and Cellular Therapy

External person

Issam Raad

  • M. D. Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Infectious Diseases
  • Department of Infectious Diseases
  • Department of Leukemia
  • University of Texas Health Science Center at Houston
  • Infectious Diseases and Employee Health

External person

Jean Yves Cahn

  • University Hospital Grenoble
  • Université de Franche-Comté
  • Universite Joseph Fourier
  • CHU de Grenoble

External person

Animesh D. Pardanani

  • Mayo Clinic Rochester, MN
  • Mayo Clinic College of Medicine and Science
  • Department of Internal Medicine
  • Divisions of Cardiovascular Diseases and Pediatric Cardiology, Departments of Medicine, Pediatrics, and Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic
  • Department of Hematology
  • Mayo Clinic College of Medicine and Science

External person

Rammurti T. Kamble

  • Baylor College of Medicine

External person

Michael J. Keating

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Jianhua Zhang

  • University of Texas MD Anderson Cancer Center
  • National Institutes of Health
  • University of Texas Health Science Center at Houston

External person

Harry P. Erba

  • University of Alabama at Birmingham
  • UAB Comprehensive Cancer Center
  • Division of Hematology and Oncology
  • Duke University

External person

Kwang Woo Ahn

  • Medical College of Wisconsin
  • Division of Biostatistics
  • TOPS Obesity and Metabolic Research Center
  • Center for International Blood and Marrow Transplant Research

External person

P. Andrew Futreal

  • Wellcome Sanger Institute
  • University of Texas MD Anderson Cancer Center
  • Institute ForAppliedCancer Science, Department of Genomic Medicine, University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Pei Lin

  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • The University of Texas MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center

External person

Iman Jilani

  • Quest Diagnostics Incorporated
  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center

External person

Jason Gotlib

  • Stanford University
  • Department of Medicine
  • Department of Medicine (Hematology)

External person

C. Hosing

  • University of Texas MD Anderson Cancer Center
  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas Health Science Center at Houston

External person

Edward Copelan

  • Carolinas Health Care System
  • Cleveland Clinic Foundation
  • Carolinas Healthcare System Reproductive Medicine and Infertility
  • Levine Cancer Institute
  • Carolinas HealthCare System

External person

Hsiang Chun Chen

  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • University of Texas Health Science Center at Houston

External person

Amber Fullmer

  • University of Texas at Austin
  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Bipin N. Savani

  • Vanderbilt University
  • Division of Nephrology

External person

David A. Rizzieri

  • Duke University

External person

Hady Ghanem

  • Lebanese American University
  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Delphine Rea

  • Université Paris 7
  • Université Paris Cité

External person

Mukta Arora

  • Center for International Blood and Marrow Transplant Research
  • University of Minnesota Twin Cities
  • Division of Hematology-Oncology and Transplantation
  • Fairview Health Service

External person

Christian Recher

  • Université Paul Sabatier Toulouse III
  • Hôpital Purpan
  • CHU de Toulouse

External person

Dietger Niederwieser

  • Leipzig University

External person

Michael Heuser

  • Hannover Medical School

External person

Eric Feldman

  • Cornell University
  • Burke Cornell Medical Center

External person

Deborah Mccue

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Peter F. Thall

  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • University of Texas Health Science Center at Houston

External person

M. Michallet

  • Hôpital Édouard Herriot
  • Hematology Department 1G
  • SociétéFrançaise de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)
  • European Group for Blood and Marrow Transplantation
  • French Group of CML (Fi-LMC Group)
  • Hospices civils de Lyon
  • Hospices Civils de Lyon
  • European Group for Blood and Marrow Transplantation

External person

D. Kontoyiannis

  • MD Anderson Cancer Center
  • University of Texas MD Anderson Cancer Center
  • Department of Infectious Diseases
  • Department of Infectious Diseases
  • Department of Biostatistics
  • University of Texas Health Science Center at Houston

External person

Iman Abou Dalle

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • American University of Beirut

External person

Paul Manley

  • Univeristate Heidelberg
  • Novartis
  • Novartis Pharmaceuticals

External person

George Q. Daley

  • Harvard University
  • Nephrology Division
  • D630, Division of Pediatric Hematology/Oncology
  • Whitehead Institute for Biomedical Research
  • Boston Children's Hospital

External person

Mansour Alfayez

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia

External person

Kelly A. Soltysiak

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia

External person

Mark Routbort

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Laurie Letvak

  • University of Texas MD Anderson Cancer Center
  • Novartis Pharmaceuticals
  • Novartis Pharmaceuticals Corporation
  • Novartis Pharmaceuticals
  • Novartis
  • Department of Leukemia

External person

Sarit Assouline

  • McGill University
  • Jewish General Hospital

External person

Juan Luis Steegmann

  • Hospital Universitario de la Princesa
  • Instituto de Investigacíon Sanitaria La Fe

External person

Victor M. Rivera

  • ARIAD Pharmaceuticals, Inc.
  • Takeda Pharmaceutical Company Limited

External person

Norbert Vey

  • Aix-Marseille Université
  • University of Texas at Austin
  • University of Texas MD Anderson Cancer Center
  • Singapore General Hospital
  • University of Texas Health Science Center at Houston
  • Institut Paoli Calmettes

External person

Peter P. Ruvolo

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Internal Medicine
  • University of Texas Medical Branch at Galveston
  • University of Texas Health Science Center at Houston

External person

Cristina Papayannidis

  • University of Bologna
  • S. Orsola-Malpighi Polyclinic
  • Azienda Ospedaliero-Universitaria di Bologna Policlinico S. Orsola – Malpighi

External person

F. Cabanillas

  • University of Texas MD Anderson Cancer Center
  • Auxilio Cancer Center
  • Department of Lymphoma and Myeloma
  • University of Texas Health Science Center at Houston

External person

Tara L. Lin

  • University of Kansas

External person

Curtis E. Gumbs

  • Duke University
  • Duke University
  • Center for Human Genome Variation
  • University of Texas MD Anderson Cancer Center
  • Institute ForAppliedCancer Science, Department of Genomic Medicine, University of Texas MD Anderson Cancer Center

External person

Michael R. Grunwald

  • Carolinas Health Care System
  • Carolinas Healthcare System Reproductive Medicine and Infertility
  • Johns Hopkins University
  • Levine Cancer Institute
  • Levine Cancer Institute/Atrium Health
  • Carolinas HealthCare System
  • Levine Cancer Institute

External person

Edwin P. Alyea

  • Dana-Farber Cancer Institute
  • Department of Medical Oncology, Dana-Farber Cancer Institute

External person

Carlos Romo

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Julianne Chen

  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

W. Ma

  • Quest Diagnostics Incorporated

External person

Fabrizio Pane

  • University of Naples Federico II

External person

Gregory A. Hale

  • Johns Hopkins University
  • Johns Hopkins All Children’s Hospital

External person

Ian D. Lewis

  • Royal Adelaide Hospital
  • Royal Adelaïde Hôpital/South Australia Pathology

External person

Ahmed Aribi

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Eduardo Olavarria

  • Hospital Virgen del Camino
  • Imperial College Healthcare NHS Trust
  • Catherine Lewis Center
  • Hammersmith Hospital

External person

Carmino A. De Souza

  • Universidade Estadual de Campinas
  • Hematology and Hemotherapy Center

External person

Y. Chen

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Lymphoma and Myeloma
  • University of Texas Health Science Center at Houston

External person

M. Naveed Shaik

  • Pfizer
  • Pfizer Oncology

External person

T. Fischer

  • Otto von Guericke University Magdeburg
  • Johannes Gutenberg University Mainz
  • Harvard University

External person

Michael S. Mathisen

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Wendy Schober

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Division of Stem Cell Transplantation and Cellular Therapy

External person

S. Wen

  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • Department of Biostatistics
  • University of Texas Health Science Center at Houston

External person

Yoshihiro Inamoto

  • Fred Hutchinson Cancer Research Center
  • National Cancer Center Hospital
  • Division of Clinical Research
  • Clinical Research Division
  • National Cancer Center Japan

External person

Tessa L. Holyoake

  • University of Glasgow
  • College of Medical, Veterinary and Life Sciences
  • Glasgow Royal Infirmary
  • University of Michigan, Ann Arbor

External person

Richard E. Clark

  • Royal Liverpool and Broadgreen University Hospitals NHS Trust
  • Department of Molecular and Clinical Cancer Medicine
  • University of Liverpool
  • Liverpool University Hospitals NHS Foundation Trust

External person

Arnaud Pigneux

  • Université de Bordeaux
  • Haut-Lévêque
  • Hôpital Cardiologique du Haut-Lévêque
  • CHU de Bordeaux

External person

Carla Boquimpani

  • HEMORIO
  • Oncoclínica Centro de Tratamento Oncológico

External person

Jeff Szer

  • Royal Melbourne Hospital

External person

K. Yee

  • Princess Margaret Cancer Centre
  • University Health Network
  • University of Texas MD Anderson Cancer Center
  • Vion Pharmaceuticals Inc.
  • Princess Margaret Hospital

External person

Weidong Wendy Ma

  • Pfizer Oncology
  • Pfizer

External person

Zi Chen

  • University of Texas MD Anderson Cancer Center
  • Fudan University
  • University of Texas Health Science Center at Houston

External person

David S. Sanford

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of British Columbia
  • University of Texas Health Science Center at Houston

External person

Luis Fayad

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Lymphoma and Myeloma
  • University of Texas Health Science Center at Houston

External person

Dale Bixby

  • University of Michigan, Ann Arbor
  • Life Sciences Institute, Division of Hematology-Oncology, University of Michigan
  • University of Michigan

External person

Jessica K. Altman

  • Robert H. Lurie Compreh. Cancer Ctr.
  • Northwestern University
  • Department of Medicine

External person

Alwin Krämer

  • German Cancer Research Center
  • Heidelberg University 

External person

James M. Foran

  • Mayo Clinic Jacksonville, FL
  • University of Alabama at Birmingham
  • BirminghamComprehensive Cancer Center

External person

Kathryn E. Flynn

  • Medical College of Wisconsin

External person

Min Du

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia

External person

Xiaochun Zhu

  • TOPS Obesity and Metabolic Research Center
  • Medical College of Wisconsin
  • Center for International Blood and Marrow Transplant Research
  • Center for International Blood and Marrow Transplant Research

External person

Hartmut Döhner

  • Ulm University
  • Department of Internal Medicine III

External person

Armand Glassman

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Department of Bioimmunotherapy
  • University of Texas at Austin
  • University of Texas Health Science Center at Houston

External person

Yuanqing Yan

  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • University of Texas Health Science Center at Houston
  • Northwestern University
  • University of Florida

External person

Jacob M. Rowe

  • Rambam Health Care Campus Israel
  • University of Texas MD Anderson Cancer Center
  • Shaare Zedek Medical Center
  • Northwestern University
  • University of Rochester
  • Technion-Israel Institute of Technology

External person

Vivian R. Ruvolo

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Division of Stem Cell Transplantation and Cellular Therapy

External person

Aref Al-Kali

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Hematology
  • Mayo Clinic Rochester, MN
  • University of Texas Health Science Center at Houston

External person

A. Megan Cornelison

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas Health Science Center at Houston

External person

Mirjana Zeremski

  • Pfizer Oncology
  • Pfizer

External person

Alan List

  • University of South Florida
  • University of Arizona

External person

Eunice S. Wang

  • Roswell Park Cancer Institute
  • Immunology
  • Department of Medicine

External person

Guy Gammon

  • Daiichi Sankyo Pharma Development
  • Ambit Biosciences
  • Inc.
  • Daiichi Sankyo Company, Limited

External person

Jeffrey Skinner

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia

External person

Nicholas C.P. Cross

  • Imperial College London
  • Imperial College Healthcare NHS Trust
  • Wessex Regional Genetics Laboratory
  • University of Southampton
  • Hammersmith Hospital

External person

Guido Marcucci

  • OHIO STATE UNIVERSITY
  • Ohio State University
  • Wexner Medical Center
  • Department of Internal Medicine, Division of Hematology, Ohio State University
  • Department of Molecular Virology, Immunology and Medical Genetics
  • Division of Human Cancer Genetics
  • City of Hope National Med Center
  • Division of Hematology

External person

Y. Shou

  • Department of Oncology
  • Novartis USA
  • Novartis Pharmaceuticals
  • Novartis

External person

David Marin

  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas MD Anderson Cancer Center
  • Imperial College Healthcare NHS Trust
  • Imperial College London
  • Hammersmith Hospital

External person

Chul S. Ha

  • University of Texas MD Anderson Cancer Center
  • Children's Memorial Hospital
  • Department of Radiation Oncology
  • University of Texas Health Science Center at Houston

External person

Rajesh R. Singh

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

N. Hamerschlak

  • Hospital Israelita Albert Einstein
  • Centro de Hematologia de

External person

Richard A. Van Etten

  • University of California at Irvine

External person

Walter Fiedler

  • University Medical Center Hamburg-Eppendorf

External person

Brian A. Jonas

  • University of California at Davis

External person

Jianxiang Wang

  • Chinese Academy of Medical Sciences

External person

Margaret Dugan

  • Univeristate Heidelberg
  • Novartis
  • Novartis Pharmaceuticals Corporation
  • Novartis Pharmaceuticals

External person

Frederick R. Appelbaum

  • Fred Hutchinson Cancer Research Center
  • University of Washington
  • Clinical Research Division

External person

Laura Fogliatto

  • Universidade Federal do Rio Grande do Sul

External person

Zhuang Zuo

  • Medical College of Georgia
  • Department of Physiology and Endocrinology, Medical College of Georgia
  • Augusta University
  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Nigel Russell

  • Nottingham University Hospitals NHS Trust

External person

Annie Claude Benichou

  • A Wholly Owned Subsidiary of Teva Branded Pharmaceutical Products RandD, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Cephalon, Inc.
  • Stragen Services SAS

External person

Edmund K. Waller

  • Emory University
  • Hematology and Oncology Department
  • Department of Hematology and Oncology
  • Division of Cardiology
  • School of Medicine
  • Department of Hematology and Medical Oncology, Emory University School of Medicine
  • Department of Hematology and Medical Oncology

External person

Yosuke Minami

  • National Cancer Center Hospital East
  • National Cancer Center Japan

External person

Tariq Mughal

  • University of Texas Southwestern Medical Center
  • Tufts University
  • Tufts Medical Center

External person

Philipp Erben

  • Heidelberg University 

External person

Ricardo H. Alvarez

  • University of Texas MD Anderson Cancer Center
  • Division of Clinical and Translational Sciences
  • University of Texas Health Science Center at Houston
  • Cancer Treatment Centers of America

External person

Tadeusz Robak

  • Medical University of Łódź

External person

James Thompson

  • Roswell Park Cancer Institute
  • Medical College of Wisconsin

External person

M. Hamadani

  • West Virginia University
  • Osborn Hematopoietic Malignancy and Transplantation Program
  • Department of Medicine
  • Osborn Hematopoietic Malignancy and Transplantation Program
  • Medical College of Wisconsin
  • TOPS Obesity and Metabolic Research Center

External person

C. Zhu

  • Bristol-Myers Squibb

External person

Wendy Stock

  • The University of Chicago

External person

Manisha Mone

  • Novartis Pharmaceuticals Corporation
  • Novartis Pharmaceuticals
  • Novartis

External person

Yu Shen

  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • Department of Biostatistics
  • University of Texas Health Science Center at Houston

External person

Anna M. Eiring

  • Department of Molecular Virology, Immunology and Medical Genetics
  • Ohio State University
  • University of Utah
  • Huntsman Cancer Institute
  • Human Cancer Genetics Program

External person

Ann Woolfrey

  • Fred Hutchinson Cancer Research Center
  • Cleveland Clinic Foundation

External person

M. Brigid Bradley-Garelik

  • Bristol-Myers Squibb

External person

Vikas Gupta

  • University Health Network
  • University of Toronto
  • Princess Margaret Hospital
  • Emory University

External person

B. Simonsson

  • Uppsala University

External person

Christopher A. Eide

  • Oregon Health and Science University
  • Howard Hughes Medical Institute
  • Division of Hematology and Medical Oncology

External person

Zimu Gong

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • AMITA Health St Joseph Hospital
  • University of Texas Health Science Center at Houston

External person

Ronald M. Sobecks

  • Cleveland Clinic Foundation
  • Department of Hematology/Medical Oncology
  • Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic

External person

Stephanie Lustgarten

  • ARIAD Pharmaceuticals, Inc.
  • Takeda Pharmaceutical Company Limited

External person

Daniel A. Pollyea

  • University of Colorado Denver
  • University of Colorado Anschutz Medical Campus

External person

Timothy Clackson

  • ARIAD Pharmaceuticals, Inc.

External person

Martha Wadleigh

  • Medical College of Wisconsin
  • Dana-Farber Cancer Institute
  • Department of Medical Oncology, Dana-Farber Cancer Institute

External person

S. G. O'Brien

  • Newcastle University
  • Newcastle upon Tyne Hospitals NHS Foundation Trust
  • Royal Victoria Infirmary

External person

Joseph O. Moore

  • Duke University

External person

B. S. Dabaja

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas at Austin
  • Department of Radiation Oncology
  • University of Texas Health Science Center at Houston

External person

Steven Coutre

  • Stanford University
  • Division of Otolaryngology/Head and Neck Surgery

External person

Uri Rozovski

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Tel Aviv University
  • University of Texas Health Science Center at Houston

External person

Brian Bolwell

  • Cleveland Clinic Foundation
  • Department of Hematology and Oncology

External person

Juliana M. Benito

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Samer Khaled

  • City of Hope National Med Center
  • City of Hope

External person

Akil Merchant

  • University of Southern California
  • Department of Medicine
  • Cedars-Sinai Medical Center

External person

R. Z. Orlowski

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Department of Lymphoma and Myeloma
  • University of Texas Health Science Center at Houston

External person

Hesham Mohamed

  • Bristol-Myers Squibb
  • Forma Therapeutics

External person

Dennis Dong Hwan Kim

  • University Health Network
  • University of Toronto
  • Princess Margaret Hospital

External person

Latasha Little

  • University of Texas MD Anderson Cancer Center
  • Institute ForAppliedCancer Science, Department of Genomic Medicine, University of Texas MD Anderson Cancer Center

External person

Ravin J. Garg

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Anthony Murgo

  • University of Texas MD Anderson Cancer Center
  • National Institutes of Health
  • Division of Cancer Treatment and Diagnosis
  • Investigational Drug Branch
  • University of Texas Health Science Center at Houston

External person

Luciano J. Costa

  • University of Alabama at Birmingham
  • Medical University of South Carolina
  • Division of Hematology/Oncology, Department of Medicine, Medical University of South Carolina

External person

Mona Lisa Alattar

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas at Dallas
  • University of Texas Health Science Center at Houston
  • University of Texas Southwestern Medical Center

External person

Kevin P. Weinfurt

  • Duke University

External person

Christopher D. Turner

  • ARIAD Pharmaceuticals, Inc.

External person

Debra Resta

  • University of Texas MD Anderson Cancer Center
  • Novartis Pharmaceuticals Corporation
  • Novartis Pharmaceuticals
  • Novartis
  • University of Texas Health Science Center at Houston

External person

Maria R. Khouri

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia

External person

P. Y. Mak

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia

External person

Michael C. Heinrich

  • Oregon Health and Science University
  • Veterans Affairs Portland Health Care System

External person

Ken H. Young

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Kimmo Porkka

  • University of Helsinki
  • Helsinki University Central Hospital

External person

Justin M. Watts

  • University of Miami

External person

Alireza Eghtedar

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Fredrick Hagemeister

  • University of Texas MD Anderson Cancer Center
  • Department of Lymphoma and Myeloma
  • University of Texas Health Science Center at Houston

External person

N. J. Gallagher

  • Department of Oncology
  • Novartis

External person

Jack W. Hsu

  • University of Florida
  • Department of Medicine

External person

Anjali S. Advani

  • Cleveland Clinic Foundation
  • Dana-Farber Cancer Institute
  • Department of Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic

External person

Sean M. Post

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Steven Z. Pavletic

  • National Institutes of Health
  • Experimental Transplantation and Immunology
  • National Institutes of Health
  • Experimental Immunology and Transplantation Branch
  • Lab. of Tumor Immunology and Biology
  • Center for Cancer Research
  • National Institutes of Health, Bethesda

External person

Arnon Nagler

  • Sheba Medical Center at Tel Hashomer

External person

Simon Durrant

  • Royal Brisbane and Women's Hospital
  • Royal Brisbane and Women's Hospital

External person

Aaron Gerds

  • Cleveland Clinic Foundation

External person

Thomas O'Hare

  • Oregon Health and Science University
  • Division of Hematology and Medical Oncology
  • University of Utah
  • Division of Hematology and Hematologic Malignancies
  • Huntsman Cancer Institute
  • Knight Cancer Institute

External person

Susie Mallard

  • University of Texas MD Anderson Cancer Center

External person

Arturo Vega-Ruiz

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Philippe Schafhausen

  • University Medical Center Hamburg-Eppendorf

External person

Li Lin

  • Duke University

External person

Megan Breeden

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Alois Gratwohl

  • University of Basel

External person

Ashleigh O'Connell

  • Pfizer Oncology

External person

Eric Bleickardt

  • Bristol-Myers Squibb

External person

Roberto M. Nussenzveig

  • University of Texas MD Anderson Cancer Center
  • University of Utah
  • University of Texas Health Science Center at Houston

External person

S. R. Solomon

  • National Institutes of Health
  • National Institutes of Health
  • Hematology Branch
  • Northside Hospital

External person

Siddhartha Ganguly

  • University of Kansas

External person

Juliana E. Hidalgo

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center

External person

Feng Wang

  • University of Texas MD Anderson Cancer Center

External person

N. Gattermann

  • Heinrich Heine University Düsseldorf

External person

Koen M. van Besien

  • Cornell University
  • Department of Medicine

External person

Leila Alland

  • Univeristate Heidelberg
  • Novartis

External person

Alice Lynn

  • University of Texas MD Anderson Cancer Center
  • St. Vincent's Hospital Melbourne

External person

Shilpa Paul

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia

External person

G. Alatrash

  • University of Texas MD Anderson Cancer Center
  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas Health Science Center at Houston

External person

Katja Karjalainen

  • University of Texas MD Anderson Cancer Center
  • University of Helsinki
  • MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Harry C. Schouten

  • Maastricht University

External person

Qaiser Bashir

  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Gabriel Etienne

  • Centre Georges-François Leclerc
  • French Group of CML (Fi-LMC Group)
  • Centre Léon Bérard

External person

Erkki Koivunen

  • University of Texas MD Anderson Cancer Center
  • University of Helsinki
  • Department of Leukemia

External person

Wadih Arap

  • University of Texas MD Anderson Cancer Center
  • University of New Mexico
  • Department of Internal Medicine
  • University of Texas Health Science Center at Houston
  • Rutgers - The State University of New Jersey, New Brunswick
  • Rutgers - The State University of New Jersey, Newark
  • University of Medicine and Dentistry of New Jersey

External person

Sangbum Choi

  • University of Texas MD Anderson Cancer Center
  • Department of Biostatistics
  • Department of Internal Medicine
  • University of Texas Health Science Center at Houston
  • Department of Leukemia

External person

Y. Wei

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Efrosyni Apostolidou

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia

External person

James P. Allison

  • Memorial Sloan-Kettering Cancer Center
  • Howard Hughes Medical Institute
  • Department of Immunology
  • University of Texas MD Anderson Cancer Center
  • University of California at Berkeley
  • Immunology Program and Department of Medicine
  • Department of Immunology
  • Immunol. Prog. and Dept. of Medicine
  • Howard Hughes Medical Institute
  • Howard Hughes Medical Institute
  • University of Texas Health Science Center at Houston

External person

John M. Pagel

  • Swedish Medical Center
  • Fred Hutchinson Cancer Research Center
  • University of Washington

External person

Arthur C. Louie

  • Jazz Pharmaceuticals
  • Celator Pharmaceuticals, Inc.
  • Inc.

External person

Brian Leber

  • McMaster Univ. Hlth. Sciences Centre
  • McMaster University
  • Department of Biochemistry
  • Department of Medicine
  • Hamilton Health Sciences

External person

Roberto N. Miranda

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Erika Thompson

  • University of Texas MD Anderson Cancer Center
  • Department of Genetics

External person

J. Q. Guo

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Renata Pasqualini

  • University of Texas MD Anderson Cancer Center
  • University of New Mexico
  • Department of Internal Medicine
  • University of Texas Health Science Center at Houston

External person

Olatoyosi Odenike

  • The University of Chicago

External person

Mitchell Sabloff

  • University of Ottawa
  • Department of Medicine
  • Ottawa Hospital Research Institute

External person

Inge H. Dufva

  • University of Copenhagen

External person

Keith W. Pratz

  • Johns Hopkins University
  • Department of Oncology
  • Sidney Kimmel Comprehensive Cancer Center, Department of Oncology, Johns Hopkins University

External person

Amin Alousi

  • Division of Stem Cell Transplantation and Cellular Therapy
  • University of Texas MD Anderson Cancer Center

External person

Ann Cahill

  • Vion Pharmaceuticals Inc.

External person

Naeem Chaudhri

  • King Faisal Specialist Hospital and Research Centre
  • Alfaisal University

External person

Shouryadeep Srivastava

  • Millennium Pharmaceuticals
  • Inc.

External person

Juergen Thiele

  • University of Cologne

External person

Zhen Huan Hu

  • Medical College of Wisconsin

External person

Beatriz Moiraghi

  • Hospital General de Agudos José María Ramos Mejía

External person

John T. Manning

  • University of Texas MD Anderson Cancer Center
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

James D. Griffin

  • Dana-Farber Cancer Institute
  • Division of Hematologic Malignancies
  • Dana Farber Cancer Center

External person

Amit Lahoti

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Mario Sznol

  • National Institutes of Health
  • Pathology and Ultrastructural Oncology Section
  • Public Health Service contract
  • Clinical Research Branch, Biological Response Modifiers Program
  • Cancer Treatment Evaluation Program
  • National Cancer Institute-Frederick Cancer Research
  • NCI-FCRDC
  • Vion Pharmaceuticals Inc.
  • Yale University
  • Yale Cancer Center

External person

Fabian Lang

  • Goethe University Frankfurt

External person

Ronan T. Swords

  • University of Miami

External person

Bruce D. Cheson

  • National Institutes of Health
  • Medicine Branch
  • University of Texas MD Anderson Cancer Center
  • Georgetown University

External person

Denise Trone

  • Independent Consultant
  • Daiichi Sankyo Pharma Development
  • Ambit Biosciences
  • Daiichi Sankyo Company, Limited
  • Independent Consultant

External person

P. H. Wiernik

  • Yeshiva University
  • Cancer Research Foundation of New York
  • Cancer Research Foundation
  • Montefiore Health System
  • Our Lady of Mercy Medical Center

External person

A. H. Sarris

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Hygeia Hospital
  • Department of Lymphoma and Myeloma
  • University of Texas Health Science Center at Houston

External person

James Gajewski

  • Department of Hematology
  • Oregon Health and Science University
  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Tillmann Krahnke

  • Novartis
  • Novartis Pharmaceuticals

External person

Jairo Matthews

  • University of Texas MD Anderson Cancer Center

External person

Sergey Voloshin

  • Russian Research Institute of Hematology and Transfusiology

External person

Cecilia Arana-Yi

  • Hospital Nacional Edgardo Rebagliati Martins
  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of New Mexico

External person

Zach Bohannan

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Xiaowei Ren

  • Inc.
  • Takeda Development Center Americas

External person

Matjaz Sever

  • University of Texas MD Anderson Cancer Center
  • University of Ljubljana
  • University of Texas Health Science Center at Houston

External person

Tamas Masszi

  • Szent Laszlo Hospital

External person

N. J. Donato

  • University of Texas MD Anderson Cancer Center
  • MD Anderson Cancer Center
  • Department of Experimental Therapeutics
  • University of Michigan, Ann Arbor
  • Life Sciences Institute

External person

Mario Annunziata

  • Azienda Ospedaliera di Rilievo Nazionale Antonio Cardarelli

External person

Andre Abdo

  • Universidade de São Paulo
  • Universidade Federal do Rio Grande do Sul

External person

R. Digumarti

  • Nizam Institute of Medical Sciences
  • Nizam's Institute of Medical Sciences

External person

Lynette C.Y. Chee

  • Peter Maccallum Cancer Centre
  • Royal Melbourne Hospital

External person

Lina Han

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Harbin Medical University
  • University of Texas Health Science Center at Houston

External person

Sara S. Strom

  • University of Texas MD Anderson Cancer Center
  • Department of Epidemiology
  • Department of Epidemiology
  • Department of Epidemiology
  • University of Texas Health Science Center at Houston

External person

Andrea Viqueira

  • Saint Louis University
  • Pfizer

External person

Yasmin Abaza

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • Northwestern University

External person

Jeroen J.W.M. Janssen

  • University of Amsterdam
  • Vrije Universiteit Amsterdam
  • Vrije Universiteit Medisch Centrum
  • Academic Medical Center
  • Amersterdam University Medical Centers

External person

Ronald Hoffman

  • Icahn School of Medicine at Mount Sinai

External person

Yeow Tee Goh

  • Singapore General Hospital

External person

Ahmad S. Alotaibi

  • University of Texas MD Anderson Cancer Center

External person

R. Bhatia

  • City of Hope National Med Center
  • Cincinnati Children's Hospital Medical Center
  • Medical Center
  • University of Alabama at Birmingham
  • Division of Hematology and Oncology

External person

Nianxiang Zhang

  • University of Texas MD Anderson Cancer Center
  • Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston
  • Life Technologies Corporation
  • Life Technologies
  • Ohio State University

External person

Yi Hua Qiu

  • University of Texas MD Anderson Cancer Center
  • Department of Leukemia
  • University of Texas Health Science Center at Houston

External person

Maria R. Baer

  • Roswell Park Cancer Institute
  • Leukemia Section
  • Johns Hopkins University
  • University of Maryland, Baltimore
  • University of Maryland Greenbaum Cancer Center

External person

D. G. Gilliland

  • Harvard University
  • Department of Medicine
  • Howard Hughes Medical Institute
  • Dana-Farber Cancer Institute
  • Brigham and Women’s Hospital
  • Harvard Institutes of Medicine

External person

J. Prchal

  • University of Alabama
  • University of Utah
  • Department of Medicine, University of Alabama at Birmingham
  • University of Alabama at Birmingham
  • Medical College of Georgia
  • Department of Cell and Molecular Biology
  • Hematology Division
  • Hematology Division
  • School of Medicine
  • Augusta University
  • Charles University

External person

Zhi Xiang Shen

  • Shanghai Jiao Tong University

External person

Ellin Berman

  • Memorial Sloan-Kettering Cancer Center

External person

Catriona Jamieson

  • University of California at San Diego
  • Sanford Stem Cell Clinical Center

External person

Xingzhi Song

  • National Institutes of Health
  • University of Texas MD Anderson Cancer Center
  • Cancer Genome Atlas Program Office, National Cancer Institute at NIH, Bldg. 31
  • Institute ForAppliedCancer Science, Department of Genomic Medicine, University of Texas MD Anderson Cancer Center

External person

Mercedes Gorre

  • Quest Diagnostics Incorporated
  • Combimatrix

External person

Dragana Milojkovic

  • Imperial College Healthcare NHS Trust
  • Hammersmith Hospital

External person

Daniel H. Ryan

  • University of Rochester

External person

Paolo Neviani

  • Department of Molecular Virology, Immunology and Medical Genetics
  • Ohio State University
  • Human Cancer Genetics Program

External person

Anupriya Agarwal

  • Oregon Health and Science University
  • Division of Hematology and Medical Oncology

External person

Mei Jie Zhang

  • Medical College of Wisconsin
  • Department of Biostatistics
  • Center for International Blood and Marrow Transplant Research

External person

Daisuke Nakada

  • Baylor College of Medicine
  • University of Texas MD Anderson Cancer Center

External person

Andrew Daly

  • Alberta Health Services
  • Tom Baker Cancer Center

External person

Michael A. Caligiuri

  • Ohio State Comprehensive Cancer Center
  • Ohio State University
  • Department of Internal Medicine, Division of Hematology, Ohio State University
  • Department of Molecular Virology, Immunology and Medical Genetics
  • Division of Human Cancer Genetics
  • City of Hope National Med Center
  • City of Hope

External person

N. T. Ueno

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person

Farshid Dayyani

  • University of Texas MD Anderson Cancer Center
  • University of Texas Health Science Center at Houston

External person